TGFBR2 and hepatocellular carcinoma: H19 was upregulated in HCC tumors generated upon the deletion of Transforming growth factor-β receptor 2 (TGFBR2) via the activation of the transcription factor SOX2, and H19 knockdown inhibited TGFBR2-deletion-induced HCC [140].